Menopause
Article
An app to help women and clinicians manage menopausal symptoms
This menopause app facilitates personalized treatment decisions
In North America, women experience menopause (the permanent cessation of...
Clinical Review
2019 Update on menopause
What is the risk of endometrial cancer in women with postmenopausal bleeding, and who should be evaluated? Plus, consensus...
Clinical Review
What to do when a patient presents with breast pain
Most breast pain is due to hormonal and fibrocystic changes, with conservative measures and patient reassurance prioritized. Here, types of breast...
Conference Coverage
Online counseling clarifies treatment options for menopausal women
NASHVILLE, TENN. – Of 36 women who completed the counseling, 72% were able to express a clear preference for a...
Gynecologic Oncology Consult
Discuss compounded bioidentical hormones and cancer risk
Patients who desire compounded bioidentical hormone preparations should be counseled that little is known about the safety of these preparations,...
Sponsored Supplement
Focus on Fracture to Help Identify Postmenopausal Osteoporosis
Brought to you by Radius Health, Inc.
News
Romosozumab gets FDA approval for treating osteoporosis
The pair of injections mainly works by encouraging new bone formation.
Expert Commentary
What is the association of menopausal HT use and risk of Alzheimer disease?
Women with Alzheimer disease (AD) were more likely to have used postmenopausal systemic hormone therapy (HT)...
Conference Coverage
Fezolinetant looks good for hot flashes in phase 2b trial
NEW ORLEANS – Big reductions in vasomotor symptoms were seen despite a strong placebo response for this nonhormonal therapy.
Conference Coverage
Biomarkers predict VTE risk with menopausal oral hormone therapy
CHICAGO – Pretreatment high D-dimer spells 500% increased VTE risk on oral hormone therapy.
Expert Commentary
Is vaginal estrogen used for GSM associated with a higher risk of CVD or cancer?
No. Vaginal estrogen use (average duration of use, 37.5 months) for genitourinary symptoms of menopause (GSM)...
Expert Commentary
Does the type of menopausal HT used increase the risk of venous thromboembolism?
Yes, according to a case-control study that analyzed data from 2 large UK databases in which 80,396 women aged...